(Q33983915)

30 July 2017

1 reference

title

Safety of inhaled and intranasal corticosteroids: lessons for the new millennium (English)

1 reference

30 July 2017

B J Lipworth

1

1 reference

30 July 2017

C M Jackson

series ordinal

2

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

11-33

1 reference

Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions

30 July 2017

cites work

1 reference

12 December 2020

Therapeutic ratio of inhaled fluticasone

1 reference

12 December 2020

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

1 reference

12 December 2020

Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids

1 reference

12 December 2020

Binding affinities of mometasone furoate and related compounds including its metabolites for the glucocorticoid receptor of rat skin tissue

1 reference

12 December 2020

Acute adrenal insufficiency in a patient with asthma after changing from fluticasone propionate to budesonide

1 reference

12 December 2020

Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17α,21-dipropionate in human liver and lung homogenate

1 reference

12 December 2020

Development of fluticasone propionate and comparison with other inhaled corticosteroids

1 reference

12 December 2020

Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate

1 reference

12 December 2020

In vivo modulation of glucocorticoid receptor mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma

1 reference

12 December 2020

The human pharmacology of fluticasone propionate

1 reference

12 December 2020

Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration

1 reference

12 December 2020

Pharmacokinetics of inhaled drugs

1 reference

12 December 2020

Effects of dose and dosing schedule of inhaled budesonide on bone turnover

1 reference

12 December 2020

Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults

1 reference

12 December 2020

Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line In vitro

1 reference

12 December 2020

Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells

1 reference

12 December 2020

Hypoglycemia and cortisol deficiency associated with low-dose corticosteroid therapy for asthma

1 reference

12 December 2020

Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder

1 reference

12 December 2020

Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis

1 reference

12 December 2020

New perspectives on inhaled drug delivery and systemic bioactivity

1 reference

12 December 2020

Pharmacokinetics and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhaler

1 reference

12 December 2020

Fortnightly review: modern drug treatment of chronic asthma

1 reference

12 December 2020

Adrenal suppression secondary to inhaled fluticasone propionate

1 reference

12 December 2020

Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function

1 reference

12 December 2020

Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate

1 reference

12 December 2020

Asthma management with HFA-BDP (Qvar)

1 reference

12 December 2020

A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler

1 reference

12 December 2020

Congenital malformations after the use of inhaled budesonide in early pregnancy

1 reference

12 December 2020

Asthma and Cushing's syndrome

1 reference

12 December 2020

Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids

1 reference

12 December 2020

Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray

1 reference

12 December 2020

In vitro properties of pressurized metered dose inhalers with and without spacer devices

1 reference

12 December 2020

Differences in lung bioavailability between different propellants for fluticasone propionate

1 reference

12 December 2020

Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma.

1 reference

12 December 2020

Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids

1 reference

12 December 2020

Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue

1 reference

12 December 2020

Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages

1 reference

12 December 2020

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis

1 reference

12 December 2020

The use of low doses of ACTH in the investigation of adrenal function in man

1 reference

12 December 2020

Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.

1 reference

12 December 2020

Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid

1 reference

12 December 2020

24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids

1 reference

12 December 2020

Pharmacokinetics of triamcinolone acetonide and its phosphate ester

1 reference

12 December 2020

International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group

1 reference

12 December 2020

Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma

1 reference

12 December 2020

The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis

1 reference

12 December 2020

Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children

1 reference

12 December 2020

Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics

1 reference

12 December 2020

Attained adult height after childhood asthma: effect of glucocorticoid therapy

1 reference

12 December 2020

Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy

1 reference

12 December 2020

Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity

1 reference

12 December 2020

Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland

1 reference

12 December 2020

Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function

1 reference

12 December 2020

Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate

1 reference

12 December 2020

Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis

1 reference

12 December 2020

Inhaled corticosteroid use and bone-mineral density in patients with asthma

1 reference

12 December 2020

Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate

1 reference

12 December 2020

Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids

1 reference

12 December 2020

A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler

1 reference

12 December 2020

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

12 December 2020

Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis

1 reference

12 December 2020

Acute adrenal insufficiency associated with high dose inhaled steroids

1 reference

12 December 2020

Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone

1 reference

12 December 2020

Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients

1 reference

12 December 2020

Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study

1 reference

12 December 2020

Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group

1 reference

12 December 2020

Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens

1 reference

12 December 2020

Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide

1 reference

12 December 2020

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

12 December 2020

Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate

1 reference

12 December 2020

Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma

1 reference

12 December 2020

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant

1 reference

12 December 2020

An in vitro comparison of commonly used topical glucocorticoid preparations

1 reference

12 December 2020

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

12 December 2020

Use of spacers to facilitate inhaled corticosteroid treatment of asthma

1 reference

12 December 2020

Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers?

1 reference

12 December 2020

Cushing's syndrome from an inhaled glucocorticoid

1 reference

12 December 2020

Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate

1 reference

12 December 2020

10.2165/00002018-200023010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1010428006

0 references

1 reference